Lissencephaly is a spectrum of rare, genetic disorders in which the brain fails to develop its hallmark folds. The disorders…
Read More »potential
If KMI closes above $27.50 at expiration on January 17, we would earn $0.78 per share on $26.72 at risk,…
Read More »If GEN closes above $28.00 on January 17, we will be assigned and earn $0.75 per share on $27.25 per…
Read More »SPOILER ALERT: This article contains details on the plot and ending of “Carry-On,” now streaming on Netflix. In “Carry-On,” Sofia…
Read More »A study from University of Michigan researchers may provide an explanation for why some patients with Crohn’s disease continue to…
Read More »If RRR closes above $45 on January 17, you would be assigned and earn $1.50 per share on $43.50 at…
Read More »Patients will be better able to benefit from innovations in medical artificial intelligence (AI) if a new set of internationally-agreed…
Read More »Key Takeaways The U.S. Supreme Court on Jan. 10 will hear arguments brought by TikTok and several of its users…
Read More »The Xbox Series X was the perfect opportunity for Microsoft to run far away from its tumultuous Xbox One years…
Read More »Australian-led research is unlocking new ways for immunotherapy to better target cancer. Cancer immunotherapy has revolutionised treatment for patients, whereby…
Read More »